
AI Tool Predicts Cancer Survival From Single Cells
Averaging tumor data has long blinded oncologists to the specific, high-risk cells that drive patient mortality.
Discover the newest research about AI innovations in 👤 Personalized Medicine.

Averaging tumor data has long blinded oncologists to the specific, high-risk cells that drive patient mortality.

A new machine learning model uses simple blood and nutrition markers to predict which uterine cancer patients can safely skip aggressive surgery to preserve their fertility.

A new machine learning model predicts 30-day mortality for brain bleed patients using routine clinical data instead of expensive brain scans, challenging the assumption that advanced imaging is required for accurate prognosis.

A new model bypasses complex clinical charts to predict long-term death risk using nothing but raw billing codes.

A new AI-driven blood test could soon keep thousands of women out of the imaging room by ruling out womb cancer with near-perfect accuracy.

Static bone density scans miss how a patient’s body changes over time, but a new deep learning model proves that tracking those physical trajectories can prevent missed fracture risks.

Using virtual clones to simulate disease progression could finally solve the recruitment bottleneck that stalls rare disease drug development.

A new machine learning model uses basic blood markers to predict how kidney cancer patients respond to immunotherapy.

A new digital twin model shows that one-third of heart failure patients fail cardiac therapy because surgeons are aiming at the wrong target.

By combining two different genomic signals, researchers proved that cheap, shallow DNA sequencing can catch ovarian cancer with high accuracy.